These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15655135)

  • 1. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis.
    Silva JA; Chan AW; White CJ; Collins TJ; Jenkins JS; Reilly JP; Ramee SR
    Circulation; 2005 Jan; 111(3):328-33. PubMed ID: 15655135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve.
    Mitchell JA; Subramanian R; White CJ; Soukas PA; Almagor Y; Stewart RE; Rosenfield K
    Catheter Cardiovasc Interv; 2007 Apr; 69(5):685-9. PubMed ID: 17351955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammatory response to renal artery percutaneous angioplasty with stent placement and the risk for restenosis: a pilot study.
    Brountzos EN; Tavernaraki K; Gouliamos AD; Degiannis D; Chaidaroglou A; Panagiotou I; Arsenis G; Kelekis D; Vlahakos D
    J Vasc Interv Radiol; 2009 Feb; 20(2):186-91. PubMed ID: 19084431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis.
    Silva JA; Potluri S; White CJ; Collins TJ; Jenkins JS; Subramanian R; Ramee SR
    Catheter Cardiovasc Interv; 2007 May; 69(6):902-7. PubMed ID: 17192944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of B-type natriuretic peptide to predict blood pressure improvement after percutaneous revascularisation for renal artery stenosis.
    Staub D; Zeller T; Trenk D; Maushart C; Uthoff H; Breidthardt T; Klima T; Aschwanden M; Socrates T; Arenja N; Twerenbold R; Rastan A; Sixt S; Jacob AL; Jaeger KA; Mueller C
    Eur J Vasc Endovasc Surg; 2010 Nov; 40(5):599-607. PubMed ID: 20739200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis.
    Zeller T; Frank U; Müller C; Bürgelin K; Sinn L; Bestehorn HP; Cook-Bruns N; Neumann FJ
    Circulation; 2003 Nov; 108(18):2244-9. PubMed ID: 14557357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide as a biomarker for a significant renal artery stenosis in medically refractory hypertensive patients.
    Wongpraparut N; Chulaluk K; Chirakamjanakorn S; Phankingthongkum R; Limtangturakulm S; Pongakasira R
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S164-70. PubMed ID: 23590038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
    Shang YP; Lai L; Chen J; Zhang F; Wang X
    J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal artery stent placement for restoration of renal function in hemodialysis recipients with renal artery stenosis.
    Thatipelli M; Misra S; Johnson CM; Andrews JC; Stanson AW; Bjarnason H; McKusick MA
    J Vasc Interv Radiol; 2008 Nov; 19(11):1563-8. PubMed ID: 18954765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study.
    Rocha-Singh K; Jaff MR; Rosenfield K;
    J Am Coll Cardiol; 2005 Sep; 46(5):776-83. PubMed ID: 16139124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embolic protection devices in patients with renal artery stenosis with chronic renal insufficiency: a clinical study.
    Misra S; Gomes MT; Mathew V; Barsness GW; Textor SC; Bjarnason H; McKusick MA
    J Vasc Interv Radiol; 2008 Nov; 19(11):1639-45. PubMed ID: 18789723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of plasma B-type natriuretic peptide level to identify asymptomatic hypertensive patients with abnormal diurnal blood pressure variation profiles: nondippers, extreme dippers, and risers.
    Nakatsu T; Shinohata R; Mashima K; Yuki Y; Nishitani A; Toyonaga S; Ogawa H; Hirohata S; Usui S; Kusachi S
    Hypertens Res; 2007 Jul; 30(7):651-8. PubMed ID: 17785934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.
    Araújo JP; Azevedo A; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Am J Cardiol; 2006 Nov; 98(9):1248-50. PubMed ID: 17056340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-profile stent placement with the monorail technique for treatment of renal artery stenosis: midterm results of a prospective trial.
    Müller-Hülsbeck S; Frahm C; Behm C; Schäfer PJ; Bolte H; Heller M; Jahnke T
    J Vasc Interv Radiol; 2005 Jul; 16(7):963-71. PubMed ID: 16002504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.